Although two recent studies showed that PLEK2 mRNA expression is down-regulated in multiple myeloma bone marrow progenitor cells and prostate cancer, its expression is thought to be positively correlated with the poor prognosis (Wang et al., 2020; Yang et al., 2020). This evidence concerns the gene PLEK2 and prostate carcinoma.